Results · Apr-Jun 2026
Sarda Proteins Q1 FY27 results
Sales grew 19% to ₹13 crore from ₹11 crore in Apr-Jun 2025.
Operating profit was −₹3.3 crore, an operating margin of −25.2% (down 20.6 points from a year ago).
Net profit turned positive: ₹1.7 crore against a loss of ₹0.49 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +1899%, net profit +142%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 13.0 | 11.0 | +19% |
| Operating profit (EBITDA) | -3.3 | -0.5 | n/m |
| Operating margin | −25.2% | −4.5% | −20.6 pts |
| Net profit | 1.7 | -0.5 | turns positive |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.